RemeGenix has several individuals serving as advisors to the two co-founders
in an unofficial capacity, and is currently in the process of formalizing these relationships
and will update the website with their names soon.
As the Company grows the members of its advisory board are expected to
change over time, as the needs of the Company change.
Reid Adler is the founder of Practical IP Strategy, which advises life science
enterprises in strategic planning, IP strategies, and technology transfer.
Reid also provides “virtual general counsel” support to technology companies and nonprofits
through the Law Office of Reid Adler.
Additionally, he is a founder and the CEO of FasterContracts, a new software-as-service business
devoted to accelerating and facilitating the negotiation of business agreements.
Previously, served in a number of key roles such as:
he was the Chief Legal Officer and Executive Vice President of Correlogic Systems,
a developer of blood serum-based cancer diagnostic tests,
he was the General Counsel and Secretary of the
nonprofit genomics research organization, the J. Craig Venter Institute, and
he was formerly a partner at Morgan Lewis where he was a co-leader of the law firm’s Life Sciences Practice Group
and head of the biotechnology patent practice.
Reid also was the founding Director of the NIH Office of Technology Transfer and held that position for five years
during the implementation of the Federal Technology Transfer Act.
He played a key role in developing model agreements and technology transfer policies
for the NIH intramural program, research integrity guidelines for NIH’s extramural grantees, and the Uniform Biological Material Transfer Agreement
endorsed by many government labs and academic institutions.
He holds a J.D. from The George Washington University Law School and has 30 years of experience in law and business.
Reid has testified before Congress on technology transfer policy and has taught courses such as Strategic Planning
for the Life Science Enterprise, Technology Transfer and Commercialization,
Biotechnology Patent Law and Legal Aspects of Biotechnology at Johns Hopkins, GWU Law School and the
FAES Graduate School at NIH.